1 / 27

Global Pharmaceutical Sales Force

Easy-to-use web-based database enables users to generate custom reports based upon any combination of these variables: Brand, Therapeutic area, Company, Country and Time period.

pharmaforce
Download Presentation

Global Pharmaceutical Sales Force

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Pharmaceutical Sales ForceDeployment AnalyzerEurope, India, Japan, Latin Americaand the United States

  2. GLOBAL PHARMACEUTICALSALES FORCEDEPLOYMENT ANALYZER CAPABILITIES 1

  3. GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES About PharmaForce International • Specialists in multi-client (syndicated) and proprietary sales, marketing and medical benchmarking and market research for the pharmaceutical and biotech industries • Global leaders in identifying “everything and anything” that pharmaceutical companies want to know about the operations of their competitors and perspectives of their customers • Multi-lingual staff with direct experience in the pharmaceutical industry and business intelligence • Hundreds of years of combined industry experience as District Managers, Product Managers, Medical Information Specialists, Market Research Directors, Training Managers and Country Business Unit Directors 2 Copyright 2013 by PharmaForce International R E A D I N G, P A

  4. GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES Field-Tested Primary Source Research Approach • More than 90% of the information for any project is derived from one-on-one interviews with individuals in the industry, including current and former employees of the target organizations • Interviewers draw upon their knowledge and personal experiences in the industry to form a common bond with interview targets and engage in peer-to-peer discussions about topics of common interest • Supplemented with exhaustive searches of all relevant electronic and printed databases, including PharmaForce’s proprietary databases developed over the past decade • Database of qualified contacts in the pharmaceutical industry exceeds 45,000 • Includes personnel in almost every sales and marketing function from sales representatives to senior management • Systematic, ongoing process to add new contacts 3 Copyright 2013 by PharmaForce International R E A D I N G, P A

  5. GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES Field-Tested Primary Source Research Approach (cont’d) • Typically, 25% of interviewees participate willingly, while another 25% refuse to participate • Strong interviewing skills come into play with the middle 50% as key partial pieces of data are culled from their limited responses • Ability to trade data on previously-researched companies dramatically increases the level of cooperation • One-on-one discussions with multiple knowledgeable sources result in verification of data • Outliers are quickly identified and assimilated through more interviews 4 Copyright 2013 by PharmaForce International R E A D I N G, P A

  6. GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES Field-Tested Primary Source Research Approach (cont’d) • Triangulation of data from contacts who are customers, suppliers and target company employees results in multiple confirmations of findings from all possible perspectives • Previous research experience on the topics allows for the widest possible knowledge base of the target deliverables and key resources 5 Copyright 2013 by PharmaForce International R E A D I N G, P A

  7. GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES About the Global Deployment Analyzer • Based on client requests for timely and accurate deployment and marketed product information, PharmaForce International developed the Global Pharmaceutical Sales Force Deployment Analyzer • Powerful web-based database program that covers the deployment of leading pharmaceutical companies’ sales forces in the United States, Europe, India, Japan and selected Latin American countries • Easy-to-use database contains up-to-date information on leading companies in Europe, India, Japan , Argentina, Brazil , Mexico and the United States • Continuously-updated database • As PharmaForce receives new or revised data on each of the target companies, the new data will be immediately added to the database • No waiting for the next quarterly or yearly installment 6 Copyright 2013 by PharmaForce International R E A D I N G, P A

  8. GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES About the Global Deployment Analyzer (cont’d) • Available database programs • European Deployment Analyzer database • Introduced in 2003 • Information about 25 leading pharmaceutical companies’ sales forces • Japan Deployment Analyzer database • Launched in 2009 • Information about 26 leading pharmaceutical companies’ sales forces • U.S. Deployment Analyzer database • Introduced in 2008 • Information about over 60 leading pharmaceutical companies’ sales forces 7 Copyright 2013 by PharmaForce International R E A D I N G, P A

  9. GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES About the Global Deployment Analyzer (cont’d) • India Deployment Analyzer database • Introduced in 2012 • Information about 12 leading pharmaceutical companies’ sales forces • Latin America Deployment Analyzer database • Introduced in 2012 • Information about 13 companies in Argentina, Brazil and Mexico 8 Copyright 2013 by PharmaForce International R E A D I N G, P A

  10. GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES About the Global Deployment Analyzer (cont’d) • Easy-to-use web-based database enables users to generate custom reports based upon any combination of the following variables: • Brand • Therapeutic area • Company • Country • Time period 9 Copyright 2013 by PharmaForce International R E A D I N G, P A

  11. GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES About the Global Deployment Analyzer (cont’d) • Data available in the Deployment Analyzer includes: • Total number of company Sales Representatives deployed by sales group: • Primary Care • Specialty/Hospital • Number of Sales Representatives by therapeutic area • Number of Sales Representatives (Full-Time Equivalents/FTEs) supporting individual brands • Based on “relative effort” reported by company personnel in interviews • Product priorities by each: • Sales group • Sales force (U.S. only) • Therapeutic area 10 Copyright 2013 by PharmaForce International R E A D I N G, P A

  12. GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES About the Global Deployment Analyzer (cont’d) • Average salaries and bonuses • Data available in the U.S. and Japan Deployment Analyzers also includes: • Total number of District Managers, Regional Managers and other sales management by group/division as defined by the target company • Sales group organizational structures • Call Reach & Frequency Analysis 11 Copyright 2013 by PharmaForce International R E A D I N G, P A

  13. GLOBAL PHARMACEUTICAL SALES FORCE DEPLOYMENT ANALYZER CAPABILITIES Comprehensive List of Therapeutic Areas Covered in the Database • Anti-Infectives (includes antibiotics, anti-fungals anti-virals) • Cardiovascular • CNS, Pain and Anesthesia • Dermatology • Endocrinology and Metabolic Disorders • Gastrointestinal • Gynecology/Women’s Health • Nephrology and Transplantation • Oncology and Hematology • Ophthalmology • Respiratory and Allergy • Rheumatology, Bone and Inflammation • Urology • Vaccines • Other 12 Copyright 2013 by PharmaForce International R E A D I N G, P A

  14. EUROPE DEPLOYMENT ANALYZER 13

  15. EUROPE DEPLOYMENT ANALYZER 10 Target Countries • Austria • Belgium • France • Germany • Italy • Netherlands • Spain • Sweden • Switzerland • United Kingdom 14 Copyright 2013 by PharmaForce International R E A D I N G, P A

  16. AbbVie (incl. former Solvay) Amgen Astellas AstraZeneca Bayer Biogen Idec BoehringerIngelheim Bristol-Myers Squibb Celgene Daiichi-Sankyo Eisai Eli Lilly GlaxoSmithKline Janssen Lundbeck Merck Serono Merck Sharp & Dohme (incl. former Schering-Plough) Novartis Novo Nordisk Pfizer Roche Sanofi (incl. former Genzyme) Takeda (incl. former Nycomed) Teva (incl. former Cephalon) UCB EUROPE DEPLOYMENT ANALYZER Target Companies 15 Copyright 2013 by PharmaForce International R E A D I N G, P A

  17. INDIA DEPLOYMENT ANALYZER 16

  18. AbbVie Biocon Cipla Dr. Reddy Labs Eli Lilly Fresenius Kabi Lupin Mankind Novartis Pfizer Sanofi Sun INDIA DEPLOYMENT ANALYZER Target Companies 17 Copyright 2013 by PharmaForce International R E A D I N G, P A

  19. JAPAN DEPLOYMENT ANALYZER 18

  20. AbbVie Astellas AstraZeneca Banyu (incl. former Schering-Plough) Bayer Bristol-Myers Squibb Chugai Daiichi-Sankyo Dainippon Sumitomo Eisai Eli Lilly GlaxoSmithKline Janssen Kyowa Hakko Kirin Mitsubishi Tanabe Nippon Boehringer Ingelheim Nippon Kayaku Novartis Otsuka Pfizer Sanofi Shionogi Taiho Taisho Toyama Takeda Yakult Honsha JAPAN DEPLOYMENT ANALYZER Target Companies 19 Copyright 2013 by PharmaForce International R E A D I N G, P A

  21. LATIN AMERICADEPLOYMENT ANALYZER 20

  22. AstraZeneca Bayer Boehringer Ingelheim Bristol-Myers Squibb Eli Lilly EMD Serono Genentech/Roche GlaxoSmithKline Janssen Merck Novartis Pfizer Sanofi LATIN AMERICA DEPLOYMENT ANALYZER Target Companies 21 Copyright 2013 by PharmaForce International R E A D I N G, P A

  23. U.S. DEPLOYMENT ANALYZER 22

  24. AbbVie Abbott Medical Optics Actavis(formerly Watson) Actelion Alcon (incl. Ciba Vision) Alexion Allergan Allos Amgen Astellas (incl. OSI) AstraZeneca Auxilium Bausch & Lomb (incl. former Ista) Baxter Bayer Biogen Idec BoehringerIngelheim Bristol-Myers Squibb (incl. former Amylin) Celgene (incl. former Abraxis Bioscience) Cooper Vision Cubist Daiichi-Sankyo Eisai Eli Lilly & Company EMD Serono Endo (incl. former Indevus) Ferring Forest Lab Fougera Pharmaceutical Galderma Genentech/Roche Gilead GlaxoSmithKline (incl. former Stiefel) Ipsen U.S. DEPLOYMENT ANALYZER Target Companies 23 Copyright 2013 by PharmaForce International R E A D I N G, P A

  25. Iridex J&J Ophthalmics/Vistakon Janssen Biotech (formerly Centocor) Janssen Pharmaceuticals Meda Merck (incl. former Schering-Plough and Inspire) Merz Novartis Novo Nordisk Onyx Pharmaceuticals Otsuka Pfizer (incl. former Wyeth and King) Purdue Regeneron Sanofi (incl. former Genzyme) Sanofi Pasteur Shire Sunovion (formerly Sepracor) Spectrum (incl. former Allos) Synergetics Takeda (incl. former Millennium) Teva (incl. former Cephalon) UCB Valeant (incl. former Medicis and Dermik) ViiV Healthcare United Therapeutics Warner Chilcott U.S. DEPLOYMENT ANALYZER Target Companies (cont’d) 24 Copyright 2013 by PharmaForce International R E A D I N G, P A

  26. DATABASE ACCESS 25

  27. DATABASE ACCESS Access to the Global Deployment Analyzer Database • Any employee of your organization globally may access the Deployment Analyzer at any time, 24 hours a day • Accessible from any computer in the world with Internet access • Access the Global Pharmaceutical Sales Force Deployment Analyzer online at • http://www.pharmaforce.biz/ • Support • When logged into the database, pausing the cursor over a search button will activate a description of the search function • Visit the FAQ section in the database for questions about our terminology and methodology 26 Copyright 2013 by PharmaForce International R E A D I N G, P A

More Related